Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAP kinase activated protein kinase 2 (MAPKAPK2 or MK2) is a serine/threonine-protein kinase that plays a central role in cellular responses to stress and inflammation. It is directly phosphorylated and activated by p38 mitogen-activated protein kinases (p38 MAPKs), especially under conditions of cellular or environmental stress. MK2 regulates cytokine production and inflammatory responses; controls endocytosis, cytoskeletal reorganization, cell migration, cell cycle progression, and gene expression regulation. It plays a key role in maintaining endothelial barrier integrity via actin and vimentin remodeling, important for vascular repair after injury. MK2 mediates initiation of the senescence-associated secretory phenotype (SASP) and is a potential therapeutic target for various inflammatory diseases including fibrosis, arthritis, cancer progression as well as cardiovascular disorders like pulmonary hypertension (PH).
p38 MAPK and MK2 inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAP kinase activated protein kinase 2 (MK2).